French Biotech Company AdipoPharma Secures Series A Funding for Groundbreaking Diabetes Drug
23 janv. 2023 03h10 HE
|
AdipoPharma
Newton Biocapital II Leads Funding Round For First-of-Its-Kind Drug to Treat Insulin ResistanceFirst Breakthrough Addressing Insulin Resistance in Type 2 Diabetes TreatmentSTRASBOURG, France,...
Blood Glucose Monitoring Devices Market to reach $28.76 Billion in 2030 with a CAGR of around 7.92%
02 juin 2022 11h28 HE
|
STRATEGIC MARKET RESEARCH LLP
New York, United States, June 02, 2022 (GLOBE NEWSWIRE) -- Blood glucose monitoring is the utilization of a glucose meter for monitoring and identifying the overall concentration content of glucose...
GlucoTrack, Inc. Announces Effectiveness of Corporate Name Change and Ticker Symbol Change
14 mars 2022 09h15 HE
|
GlucoTrack, Inc.
To begin trading under the Nasdaq Symbol GCTK Rutherford, NJ and Or Yehuda, Israel, March 14, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), formerly...
Cardiometabolic Diseases Market Size ($121,804.49Mn by 2028) Lead by Cardiovascular Disease (3.9% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
29 oct. 2021 09h54 HE
|
The Insight Partners
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cardiometabolic Diseases Market: Key InsightsAccording to our new research study on Cardiometabolic Diseases Market Size and Forecast to 2028 - COVID-19...
Integrity Applications, Inc. Implements Reverse Stock Split To Meet NASDAQ Initial Listing Requirements
12 août 2021 09h15 HE
|
Integrity Applications, Inc.
Wilmington, DE and Ashdod, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring...
Integrity Applications Appoints Luis J. Malavé to Board of Directors
22 juin 2021 09h00 HE
|
Integrity Applications, Inc.
WILMINGTON, Del. and ASHDOD, Israel, June 22, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for...
Diabacore Reviews – Negative Side Effects or Legit Benefits?
22 avr. 2021 19h37 HE
|
Marketing By Kevin
New York, NY, April 22, 2021 (GLOBE NEWSWIRE) -- For millions of people around the world, diabetes is a life-changing issue that will haunt them for the rest of their lives. Years and years on...
Digital Diabetes Management Market Size & Share 2021-2027 | North America, Europe, & APAC Industry Forecasts: Graphical Research
09 mars 2021 06h30 HE
|
Graphical Research
Pune, India, March 09, 2021 (GLOBE NEWSWIRE) -- The digital diabetes management market size is predicted to expand at significant CAGR during the forecast period, with the need for accurate,...
Integrity Applications Issues Shareholder Update Letter
18 févr. 2021 09h30 HE
|
Integrity Applications, Inc.
Wilmington, DE and Ashdod, Israel, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (IGAP), innovator of GlucoTrack®, a non-invasive device for measuring...
Nemaura Medical Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Corporate Update
16 févr. 2021 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...